Cargando…
Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection. It is a large contributor to infant hospitalization and also has a substantial burden in older adults ( ≥ 65 years). The non-pharmaceutical interventions that were introduced to limit the spread of SARS-CoV-2 ha...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281204/ https://www.ncbi.nlm.nih.gov/pubmed/35831610 http://dx.doi.org/10.1038/s41577-022-00764-7 |